<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cytogenetic studies were performed in 69 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> classified according to the FAB proposals </plain></SENT>
<SENT sid="1" pm="."><plain>Overall incidence of chromosomal anomalies was 48% with 5q-, +8, 12p-,-7/7q- being the aberrations most often found </plain></SENT>
<SENT sid="2" pm="."><plain>The 12p- chromosome showed a close correlation with a prior exposure to <z:chebi fb="1" ids="25435">mutagenic agents</z:chebi> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Although there were no group-specific cytogenetic anomalies, FAB classification strongly influenced their incidence </plain></SENT>
<SENT sid="4" pm="."><plain>They were lower (36%) in RA/RA-S than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB-T</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> (53%) </plain></SENT>
<SENT sid="5" pm="."><plain>Chromosomal anomalies were significantly more often found in patients with a prior exposure to <z:chebi fb="0" ids="50903">carcinogenic agents</z:chebi> (80%) than in unexposed patients (33%) </plain></SENT>
<SENT sid="6" pm="."><plain>The presence of chromosomal anomalies did not predict a higher risk of leukemic transformation </plain></SENT>
</text></document>